Novel PP2A-Activating Compounds in Neuroblastoma is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute of the National Institutes of Health
Grant: T32 CA229102
National Cancer Institute of the National Institutes of Health
Grant: 5T32GM008361
National Cancer Institute of the National Institutes of Health
Grant: P30CA013148
National Cancer Institute of the National Institutes of Health
Grant: 1R43CA268329-01
Direct Activation of PP2A as a Novel Approach to Group-3 Medulloblastoma Therapy
National Cancer Institute of the National Institutes of Health
Grant: 75N91024C00009
National Cancer Institute of the National Institutes of Health
Grant: 75N91023-C-38
National Institutes of Health
Grant: 5T32GM008361-26
Medical Scientist Training Program
National Institutes of Health
Grant: 2P30CA013148-34
TISSUE PROCUREMENT
National Institutes of Health
Grant: 5T32CA229102-08
Surgical Oncology Research Training Program
NIH HHS
Grant: 75N91024C00009, 75N91023-C-38
FWCI
1.06
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords